Publicaciones

All

Articles

Conference Papers

Books & Book Chapters

Review

Annotation

Lecture

Others

Type

By researcher

By affiliation

Title Issue Date
Sweet legacy, bitter outcomes: sugar, sweeteners, and the microbial origins of a modern syndrome. An evidence-based narrative review Ceballos Santos, Daniel Sebastián ; Caba, María; Almeida, Cristian; Crespo, Javier Issued date: 2026 DOI: 10.17235/reed.2026.11733/2025 Source: Revista espanola de enfermedades digestivas [ISSN 1130-0108] (2026). SJR: 0,284 - Q3 JCR: 4,0 - Q1 SCIE MIAR ICDS: 11,0
Building a Robust Investigator‐Initiated Platform: The I‐CARE Experience Kirchgesner, Julien; Beaugerie, Laurent; Baumann, Cédric; Baert, Filip; Rahier, Jean‐François, et al Issued date: 2026 DOI: 10.1002/cpt.70231 Source: Clinical pharmacology and therapeutics, [ISSN 0009-9236], 2026 SJR: 2,127 - Q1 JCR: 5,5 - Q1 SCIE
Safety of ustekinumab vs anti-TNF, immunomodulators, or no immunosuppressive therapy during pregnancy in IBD: DUMBO Registry Aranguren, A.; Garre, A.; Leo Carnerero, E.; Calviño Suárez, C.; Martin Arranz, M.D., et al Issued date: 2026 DOI: 10.1093/ecco-jcc/jjaf231.1139 Source: Journal of Crohn´s and Colitis [eISSN 1876-4479], v. 20 (supl. I), #jjaf231.1139 P0958, p. 2359-2362 (Enero 2026) Póster de congresos
Short-term effectiveness and safety of Mirikizumab in ulcerative colitis: real-world evidence from the ENEIDA registry of GETECCU Gutiérrez Casbas,A.; Barreiro-de Acosta,M.; De Castro Parga,M.L.; Madero Velázquez,L.; Rodríguez,C., et al Issued date: 2026 Source: Journal of Crohn´s and Colitis [eISSN 1876-4479], v. 20 (supl. I), #jjaf231.1088 P0907, p. 2255-2257 (Enero 2026) Póster de congresos
Prevalence and factors associated with inflammatory bowel disease (IBD) activity during pregnancy: updated data from the Dumbo registry Tomás,S.; Leo Carnerero, E.; Calviño Suárez, C.; Martin Arranz, M.D.; Zabalza San Martín, L., et al Issued date: 2026 DOI: 10.1093/ecco-jcc/jjaf231.081 Source: Journal of Crohn´s and Colitis [eISSN 1876-4479], v. 20 (supl. I), #jjaf231.081 DOP 044, p. 199-202 (Enero 2026) Actas de congresos
Efficacy and safety of granulocyte and monocyte apheresis (GMA) with Adacolumn® in patients with inflammatory bowel disease in real-world practice in Spain: the GRACE study. Rodríguez-Lago, I.; Cabriada Nuno, J.L.; Vicuña Arregui,M.; Leo, E.; Iglesias Flores, E., et al Issued date: 2026 DOI: 10.1093/ecco-jcc/jjaf231.905 Source: Journal of Crohn´s and Colitis [eISSN 1876-4479], v. 20 (supl. I), #jjaf231.905 P0724, p. 1881-1883 (Enero 2026) Póster de congresos
Prevalence, clinical characterisation and therapeutic outcomes of non-fistulising perianal lesions in Crohn’s disease (ULCERS-CD): Results from the ENEIDA registry of GETECCU Casanova,M.J.; De Francisco Garcia,R.M.; López Ramos,C.; Hernandez Camba,A.; Gargayo-Puyuelo,C., et al Issued date: 2026 DOI: 10.1093/ecco-jcc/jjaf231.960 Source: Journal of Crohn´s and Colitis [eISSN 1876-4479], v. 20 (supl. I), #jjaf231.960 P0779, p. 1996-1999 (Enero 2026) Póster de congresos
Feasibility and safety of endoscopic submucosal dissection In inflammatory bowel disease (ESDEUR-IBD): an European retrospective study García, M.J.; Fraile,M.; Katinios,G.; Gubbiotti, A.; Argyriou, K., et al Issued date: 2026 DOI: 10.1093/ecco-jcc/jjaf231.1281 Source: Journal of Crohn´s and Colitis [eISSN 1876-4479], v. 20 (supl. I), #jjaf231.1281 P1100, p. 2643-2646 (Enero 2026) Póster de congresos
Switching to Subcutaneous Infliximab for Regaining Clinical Remission in Inflammatory Bowel Disease Patients who lost response to Intravenous Infliximab: An Observational Study from the ENEIDA Registry Brunet, E.; Altadill, A.; Vela Gonzalez, M.M.; Calafat Sard,M.; Garcia De La Filia Molina,I., et al Issued date: 2026 DOI: 10.1093/ecco-jcc/jjaf231.1286 Source: Journal of Crohn´s and Colitis [eISSN 1876-4479], v. 20 (supl. I), #jjaf231.1286 P1105, p. 2658-2659 (Enero 2026) Póster de congresos
Comparative study on the effectiveness, durability, and safety of upadacitinib versus risankizumab after anti-TNF failure in Crohn's Disease: The U-PARIS study of ENEIDA Rubin De Celix, C.; Granja, A.; Iborra, M.; Garcia Alonso, F. J.; Vela, M., et al Issued date: 2026 DOI: 10.1093/ecco-jcc/jjaf231.069 Source: Journal of Crohn´s and Colitis [eISSN 1876-4479], v. 20 (supl. I), #jjaf231.069 164-168, DOP032, (Enero 2026) SJR: 2,991 - Q1 JCR: 8,7 - Q1 SCIE MIAR ICDS: 10,6 Actas de congresos
Calidad y seguridad del paciente Alberca de las Parras, Fernando; Albillos Martínez, Agustín; Alcaín Martínez, Guillermo José; Arévalo Serna, Juan Antonio; Argüelles Arias, Federico, et al Issued date: 2026 Libro
Healthcare Professionals' Experience with Oral Oligomeric Supplements in Malnourished Patients in Spain: S-QUEST Study Ceballos Santos, Daniel Sebastián ; Pedrianes Martín, Pablo Benito ; Lorente, María; García Puente, Ignacio ; Labrador, Blas, et al Issued date: 2025 DOI: 10.17235/reed.2025.11741/2025 Source: Revista Espanola de Enfermedades Digestivas [eISSN 1130-0108], (septiembre 2025) SJR: 0,284 - Q3 JCR: 4,0 - Q1 SCIE MIAR ICDS: 11,0 Artículo
Comparing JAK inhibitors in ulcerative colitis: which one truly leads in the real world? Results from the ENEIDA registry of GETECCU Chaparro, M.; Hermida, S.; Camargo Camero, R.; Ripoll Abadía, P.; Vela-González, M., et al Issued date: 2025 Source: European Crohn’s and Colitis Organization / #P0692: jjae190.0866, pp. 1349-1351 (Febrero 2025) Póster de congresos
Real-world short and long-term effectiveness of risankizumab in refractory Crohn’s disease: RISANCROHN study from the ENEIDA Registry Barreiro-de Acosta, M.; Nieto-Garcia, L.; Poncela, M.; Aguas, M.; Martinez Cuevas, C., et al Issued date: 2025 Source: European Crohn’s and Colitis Organization / #P0609: jjae190.0783, pp. 1208-1209 (Febrero 2025) Póster de congresos
Feasibility and safety of endoscopic submucosal dissection in inflammatory bowel disease (ESDEUR-IBD): an interim analysis of European retrospective study García, M.J.; Fraile,M.; Katinios, G.; Gubbiotti, A.; Argyriou, K., et al Issued date: 2025 Source: European Crohn’s and Colitis Organization / #P0617: jjae190.0791, pp. 1220-1221 (Febrero 2025) Ponencia
Real-world efficacy and safety of filgotinib in ulcerative colitis: results from the ENEIDA registry Rodríguez-Lago, I.; Cudero, L.; Martínez Pascual, C.; Mínguez, A.; Ferreiro-Iglesias, R., et al Issued date: 2025 Source: European Crohn’s and Colitis Organization / #P0849: jjae190.1023, pp. 1619-1620 (Febrero 2025) Póster de congresos
Effectiveness and safety of upadacitinib in ulcerative colitis in clinical practice: results from the U-REAL-UC study from ENEIDA Chaparro, M.; Hermida, S.; Zabalza San Martín, L.; Tosca Cuquerella, J.; Castro, L. de, et al Issued date: 2025 Source: European Crohn’s and Colitis Organization / #P0664: jjae190.0838, pp. 1298-1300 (Febrero 2025) Póster de congresos
Real-World Outcomes of Upadacitinib in Crohn’s Disease: Insights from ENEIDA database Iborra, M.; Botella, B.; Martín-Arranz, M.D.; Ceballos Santos, Daniel Sebastián Issued date: 2025 Source: European Crohn’s and Colitis Organization / #P0890: jjae190.1064, pp. 1685-1686 (Febrero 2025) Póster de congresos
Postoperative recurrence after a definitive ostomy in Crohn's disease. A nationwide retrospective series from the Eneida registry Calafat Sard,M.; Mañosa,M.; Fernández-Clotet,A.; Pasanau,L.; Matallana,V., et al Issued date: 2025 Source: European Crohn’s and Colitis Organization / #P0226: jjae190.0400, pp. 641-642 (Febrero 2025) Póster de congresos
Enfermedades digestivas en personas con obesidad: más allá de la pérdida de peso Crespo, Javier; Alberca, Fernando; Alonso Peña, Marta; Argüelles, Federico; Bataller, Ramón, et al Issued date: 2025 DOI: 10.17235/reed.2025.11375/2025 Source: Revista Espanola de Enfermedades Digestivas, [ISSN 113-0108], (Junio, 2025). SJR: 0,284 - Q3 JCR: 4,0 - Q1 SCIE MIAR ICDS: 11,0